Marketing-authorisation holder · Germany
Eisai Gmbh
30 medicines in 3 countries, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Germany
30 medicines in 3 countries, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 30
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| FYCOMPACompressa rivestita con film | Perampanel | Italy | Authorised | |
| Fycompa | Perampanel | EU (EMA) | Authorised | 2012 |
| Fycompa 0.5 mg/ml, suspensie voor oraal gebruikSuspensie voor oraal gebruik | Perampanel | Netherlands | Authorised | 2016 |
| Fycompa 10 mg filmomhulde tablettenFilmomhulde tablet | Perampanel | Netherlands | Authorised | 2012 |
| Fycompa 12 mg filmomhulde tablettenFilmomhulde tablet | Perampanel | Netherlands | Authorised | 2012 |
| Fycompa 2 mg filmomhulde tablettenFilmomhulde tablet | Perampanel | Netherlands | Authorised | 2012 |
| Fycompa 4 mg filmomhulde tablettenFilmomhulde tablet | Perampanel | Netherlands | Authorised | 2012 |
| Fycompa 6 mg filmomhulde tablettenFilmomhulde tablet | Perampanel | Netherlands | Authorised | 2012 |
| Fycompa 8 mg filmomhulde tablettenFilmomhulde tablet | Perampanel | Netherlands | Authorised | 2012 |
| HALAVENSoluzione iniettabile | Eribulin | Italy | Authorised | |
| Halaven | Eribulin | EU (EMA) | Authorised | 2011 |
| Halaven 0,44 mg/ml oplossing voor injectieOplossing voor injectie | Eribulin | Netherlands | Authorised | 2011 |
| Inovelon | Rufinamide | EU (EMA) | Authorised | 2007 |
| INOVELONCompressa rivestita con film | Rufinamide | Italy | Authorised | |
| Inovelon 100 mg, filmomhulde tablettenFilmomhulde tablet | Rufinamide | Netherlands | Authorised | 2007 |
| Inovelon 200 mg, filmomhulde tablettenFilmomhulde tablet | Rufinamide | Netherlands | Authorised | 2007 |
| Inovelon 40 mg/ ml, suspensie voor oraal gebruikSuspensie voor oraal gebruik | Rufinamide | Netherlands | Authorised | 2011 |
| Inovelon 400 mg, filmomhulde tablettenFilmomhulde tablet | Rufinamide | Netherlands | Authorised | 2007 |
| KISPLYXCapsula rigida | Lenvatinib | Italy | Authorised | |
| Kisplyx | Lenvatinib | EU (EMA) | Authorised | 2016 |
| Kisplyx 10 mg, harde capsuleCapsule, hard | Lenvatinib | Netherlands | Authorised | 2016 |
| Kisplyx 4 mg, harde capsuleCapsule, hard | Lenvatinib | Netherlands | Authorised | 2016 |
| Lenvima | Lenvatinib | EU (EMA) | Authorised | 2015 |
| LENVIMACapsula rigida | Lenvatinib | Italy | Authorised | |
| Lenvima 10 mg, harde capsulesCapsule, hard | Lenvatinib | Netherlands | Authorised | 2015 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 17 | 17 | 0 | CompaniesAll medicines |
| European Union (EMA) | 7 | 6 | 1 | CompaniesAll medicines |
| Italy | 6 | 6 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.